Inovia Vein Marks Milestones in Raising Vein Disease and Therapy Awareness for 2023 DVT Awareness Month

BEND, Ore.–(BUSINESS WIRE)–Inovia Vein Specialty Centers, a leading provider of vein disease treatments and therapies in the Pacific Northwest, announces its successful outreach and awareness efforts during DVT Awareness Month in March 2023. Throughout the month of March, the clinic dedicated its resources to raising awareness about the dangers of vein disease, as well as … [Read more…]

Dyve Announces Poster Presentation at 2023 AACR Annual Meeting

CAMARILLO, Calif.–(BUSINESS WIRE)–#biotechnology—Dyve Biosciences, Inc. (“Dyve”), a clinical-stage platform biotechnology company with assets in immunology and oncology, today announced that preliminary data from the ongoing pre-clinical partnership with the H. Lee Moffitt Cancer Center & Research Institute will be presented at a poster presentation at the upcoming American Association for Cancer Research (AACR) annual meeting, … [Read more…]

Quantum Sound Therapy Suggests Unusual Treatment for Adolescent Mental Health Crisis: Sound Vibrations

As researchers deepen their understanding of how sound waves affect the body, some propose using sound vibrations to relieve mental and emotional ailments HOT SPRINGS, Ariz.–(BUSINESS WIRE)–#IQubes–Between COVID-19 and a tumultuous political and social landscape, the mental health crisis in America has worsened like never before. In fact, the United States routinely spends 201 billion … [Read more…]

BeiGene and SpringWorks Present Clinical Data on Lifirafenib, in Combination with Mirdametinib, in Patients with Advanced or Refractory Solid Tumors with MAPK Pathway Aberrations at the American Association for Cancer Research Annual Meeting 2023

BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & STAMFORD, Conn.–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today announced that they will present updated clinical data from the Phase 1b trial of BeiGene’s RAF dimer inhibitor, lifirafenib, in combination with SpringWorks’ MEK inhibitor, mirdametinib, in patients with advanced … [Read more…]

MapKure, BeiGene and SpringWorks Present Clinical Data on BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors at the American Association for Cancer Research Annual Meeting 2023

BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & SAN MATEO, Calif. & STAMFORD, Conn.–(BUSINESS WIRE)–MapKure, LLC, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today announced that they will present updated clinical data from the Phase 1a/1b study of BGB-3245, an investigational, selective RAF dimer inhibitor, in adult patients … [Read more…]

Mobile Heartbeat® and Akkadian Labs Announce Technology Partnership

Streamlining the provisioning of communications and collaboration solutions for the healthcare industry WALTHAM, Mass.–(BUSINESS WIRE)–#UCProvisioning–Mobile Heartbeat, the leading clinical communication and collaboration company, is pleased to announce a new partnership with Akkadian Labs, developer of the leading unified communications (UC) provisioning automation solution for enterprises and MSPs. Our flagship product, MH-CURE® now integrates with Akkadian … [Read more…]

Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023

PASADENA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today presented new preclinical data generated from engineered CD28 bispecific antibodies targeting the solid tumor antigens CEACAM5, ENPP3, mesothelin, STEAP1 and Trop-2. For each molecule, in vitro T cell activation was enhanced in … [Read more…]

Avistone Announces Interim Data Results on PLB1004 in Patients with EGFR mutant NSCLC Patients at AACR 2023

BEIJING–(BUSINESS WIRE)–Avistone Biotechnology (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology therapeutics, today announced interim results from its ongoing phase 1 study on PLB1004. The data were presented today (CT102) at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, Florida USA. PLB1004, a novel mono-anilino-pyrimidine small molecule … [Read more…]

Sonitor Introduces SonitorBLU™ and SonitorMOBILE™

New Tiered Product Line Opens Low-Cost RTLS Entry Point for Asset Tracking “Phone as an RTLS Tag” Visit Sonitor at HIMSS – Booth #3427 CHICAGO–(BUSINESS WIRE)–Sonitor® Technologies today announced expansion of its market leading Sense™ platform with SonitorBLU, a proprietary Bluetooth Low Energy (BLE) solution for use cases when zonal accuracy is required, and SonitorMOBILE, … [Read more…]

MTF Biologics Unveils New Tissue Form: AlloPatch® Pliable Meshed – Acellular Human Reticular Dermal Allograft

Innovative allograft offers new treatment option for diabetic foot ulcers and venous leg ulcers EDISON, N.J.–(BUSINESS WIRE)–MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, is introducing AlloPatch® Pliable Meshed to its line of premier, innovative and effective wound care … [Read more…]